Page 31 - PD-L1 EbookV2 Flip PDF
P. 31
education for laboratory best practice are imperative, and pharma companies must have
direct involvement in such initiatives from the start of any drug development strategies.
We cannot let relatively easy to fix testing issues leave any patient behind.
References
1. https://clinicaltrials.gov/ct2/show/NCT02460198?term=keynote-164&rank=1
2. https://clinicaltrials.gov/ct2/show/NCT01848834?term=keynote-012&rank=1
3. https://clinicaltrials.gov/ct2/show/NCT02628067?term=keynote-158&rank=1
4. https://clinicaltrials.gov/ct2/show/record/NCT01876511
5. https://clinicaltrials.gov/ct2/show/NCT02054806?term=KEYNOTE+28&rank=1
Originally published at diaceutics.com, 5 June 2017
Page 31 of 31
